Cytogenetics and Clinical Outcomes of Plasma Cell Leukemia Patients: A Single Institution Experience by Lebovic, Daniel J., Baz, Rachid, Alsina, Melissa, Ochoa, Jose L, Sullivan, Daniel, Shain, Kenneth H, Zhang, Ling

Get full text

Evaluation of Single Agent Lenalidomide in Patients with Newly Diagnosed Multiple Myeloma (NDMM) by Baz, Rachid, Hussein, Mohamad, Lebovic, Daniel J., Finley-Oliver, Elizabeth, Patel, Mehul P, Liu, Hong, Miller, Kena C, Wood, Margaret, Lee, Kelvin P., Chanan-Khan, Asher

Get full text

Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy by Lohr, Jens G., Stojanov, Petar, Carter, Scott L., Cruz-Gordillo, Peter, Lawrence, Michael S., Auclair, Daniel, Sougnez, Carrie, Knoechel, Birgit, Gould, Joshua, Saksena, Gordon, Cibulskis, Kristian, McKenna, Aaron, Chapman, Michael A., Straussman, Ravid, Levy, Joan, Perkins, Louise M., Keats, Jonathan J., Schumacher, Steven E., Rosenberg, Mara, Anderson, Kenneth C., Richardson, Paul, Krishnan, Amrita, Lonial, Sagar, Kaufman, Jonathan, Siegel, David S., Vesole, David H., Roy, Vivek, Rivera, Candido E., Rajkumar, S. Vincent, Kumar, Shaji, Fonseca, Rafael, Ahmann, Greg J., Bergsagel, P. Leif, Stewart, A. Keith, Hofmeister, Craig C., Efebera, Yvonne A., Jagannath, Sundar, Chari, Ajai, Trudel, Suzanne, Reece, Donna, Wolf, Jeffrey, Martin, Thomas, Zimmerman, Todd, Rosenbaum, Cara, Jakubowiak, Andrzej J., Lebovic, Daniel, Vij, Ravi, Stockerl-Goldstein, Keith, Getz, Gad, Golub, Todd R.

Get full text

Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma by Dytfeld, Dominik, Jasielec, Jagoda, Griffith, Kent A, Lebovic, Daniel, Vesole, David H, Jagannath, Sundar, Al-Zoubi, Ammar, Anderson, Tara, Detweiler-Short, Kristen, Stockerl-Goldstein, Keith, Ahmed, Asra, Jobkar, Terri, Durecki, Diane E, McDonnell, Kathryn, Mietzel, Melissa, Couriel, Daniel, Kaminski, Mark, Vij, Ravi, Jakubowiak, Andrzej J

Get full text

A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma by Jakubowiak, Andrzej J., Dytfeld, Dominik, Griffith, Kent A., Lebovic, Daniel, Vesole, David H., Jagannath, Sundar, Al-Zoubi, Ammar, Anderson, Tara, Nordgren, Brian, Detweiler-Short, Kristen, Stockerl-Goldstein, Keith, Ahmed, Asra, Jobkar, Terri, Durecki, Diane E., McDonnell, Kathryn, Mietzel, Melissa, Couriel, Daniel, Kaminski, Mark, Vij, Ravi

Get full text

Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma by Shah, Jatin J, Jakubowiak, Andrzej J, O'Connor, Owen A, Orlowski, Robert Z, Harvey, R Donald, Smith, Mitchell R, Lebovic, Daniel, Diefenbach, Catherine, Kelly, Kevin, Hua, Zhaowei, Berger, Allison J, Mulligan, George, Faessel, Hélène M, Tirrell, Stephen, Dezube, Bruce J, Lonial, Sagar

Get full text

Functional Improvement Trajectories After Surgery (FIT After Surgery) study: protocol for a multicentre prospective cohort study to evaluate significant new disability after major... by Wijeysundera, Duminda N, Alibhai, Shabbir M H, Ladha, Karim S, Puts, Martine T E, Chesney, Tyler R, Daza, Julian F, Ehtesham, Sahar, Hladkowicz, Emily, Lebovic, Gerald, Mazer, C David, van Vlymen, Janet M, Wei, Alice C, McIsaac, Daniel I, Wijeysundera, DN, Ladha, KS, Daza, JF, Pazmino-Canizares, J, Mattina, G, Hladkowicz, E, Tessier, M, Ehtesham, S, Nnorom, S, Alibhai, SMH, Jüni, P, Mazer, CD, Puts, M, Lebovic, G, Chesney, TR, Wei, AC, Drozdz, S, Hanley, C, Sussman, D, Louridas, M, Wong, C, Breau, RH, Lalu, M, Abdellatif, S, Gagne, S, Duceppe, E, Davis, M, Zarnke, K, Bosch, M, Avremescu, S, Serrano, P, Van Vlymen, J, Dumerton, D, Karizhenskaia, M, El Beheiry, H, Siddiqui, N, Kennedy, E, MacDonald, D, Spence, R, Bonazza, F, Zahavich, A, Jacobsohn, E, Thorleifson, M, Russell, S L, Bagry, H, MacDonell, SY, Lyon, V, Barnes, T, Dale-Gandar, J, Choi, S, Jerath, A, Kaustov, L, Fleet, A, Shaeen, S, Lorello, G, Al Azazi, E, Parotto, M, McCluskey, S A, Poonawala, H, Dillane, D, McIsaac, Di

Get full text

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results by Richardson, Paul G., Bensinger, William I., Huff, Carol Ann, Costello, Caitlin L., Lendvai, Nikoletta, Berdeja, Jesus G., Anderson, Larry D., Siegel, David S., Lebovic, Daniel, Jagannath, Sundar, Laubach, Jacob P., Stockerl‐Goldstein, Keith E., Kwei, Long, Clow, Fong, Elias, Laurence, Salman, Zeena, Graef, Thorsten, Bilotti, Elizabeth, Vij, Ravi

Get full text

76. Clinical and Patient-Reported Outcomes of Adult Spinal Deformity Surgery with 10-Year Follow-Up by Tretiakov, Peter, Onafowokan, Oluwatobi, Das, Ankita, Lorentz, Nathan, Lebovic, Jordan, Diebo, Bassel G., Hamilton, D. Kojo, Anand, Neel, Sciubba, Daniel M., Shaffrey, Christopher I., Lafage, Renaud, Lafage, Virginie, Schoenfeld, Andrew J., Passias, Peter Gust

Get full text

Impact of Frailty on the Development of Proximal Junctional Failure: Does Frailty Supersede Achieving Optimal Realignment? by Krol, Oscar, McFarland, Kimberly, Owusu-Sarpong, Stephane, Sagoo, Navraj, Williamson, Tyler, Joujon-Roche, Rachel, Tretiakov, Peter, Imbo, Bailey, Dave, Pooja, Mir, Jamshaid, Lebovic, Jordan, Onafowokan, Oluwatobi O., Schoenfeld, Andrew J., De la Garza Ramos, Rafael, Janjua, Muhammad Burhan, Sciubba, Daniel M., Diebo, Bassel G., Vira, Shaleen, Smith, Justin S., Lafage, Virginie, Lafage, Renaud, Passias, Peter G.

Get full text

P161. Proximal junctional kyphosis and failure: How much can we attribute to known risk factors? by Onafowokan, Oluwatobi, Jankowski, Pawel P, Mir, Jamshaid, Das, Ankita, Hockley, Aaron, Lorentz, Nathan, Galetta, Matthew Steven, Lebovic, Jordan, Hamilton, D. Kojo, Diebo, Bassel G., Daniels, Alan H, Anand, Neel, Pour, Paritash Tahmaseb, Sciubba, Daniel M., Ramos, Rafael De la Garza, Shaffrey, Christopher I., Lafage, Renaud, Lafage, Virginie, Schoenfeld, Andrew J., Passias, Peter Gust

Get full text

Prevalence of Fabry Disease and Outcomes in Young Canadian Patients With Cryptogenic Ischemic Cerebrovascular Events by Lanthier, Sylvain, Saposnik, Gustavo, Lebovic, Gerald, Pope, Karen, Selchen, Daniel, Moore, David F

Get full text

Predicting mortality among critically ill patients with acute kidney injury treated with renal replacement therapy: Development and validation of new prediction models by Li, Daniel H., Wald, Ron, Blum, Daniel, McArthur, Eric, James, Matthew T., Burns, Karen E.A., Friedrich, Jan O., Adhikari, Neill K.J., Nash, Danielle M., Lebovic, Gerald, Harvey, Andrea K., Dixon, Stephanie N., Silver, Samuel A., Bagshaw, Sean M., Beaubien-Souligny, William

Get full text

Timing of introduction to solid food, eczema and wheezing in later childhood: a longitudinal cohort study by D’Hollander, Curtis J., Keown-Stoneman, Charles D. G., Birken, Catherine S., O’Connor, Deborah L., Maguire, Jonathon L., Allen, Christopher, Anderson, Laura N., D’Annunzio, Danielle, Jaleel, Mateenah, McFarlane, Natricha Levy, Omand, Jessica A., Thadani, Sharon, Aglipay, Mary, Bayoumi, Imaan, Borkhoff, Cornelia M., Carsley, Sarah, Charach, Alice, Cost, Katherine, Fuller, Anne, Kinlin, Laura, Kucab, Michaela, Li, Patricia, Parkin, Pat, Persaud, Nav, Rae, Sarah, Socynska, Izabela, Vanderhout, Shelley, Vanderloo, Leigh, Wong, Peter, Mudiyanselage, Piyumi Konara, Li, Xuedi, Liu, Jenny, Mitchell, Michelle, Yoshida-Montezuma, Yulika, Zaffar, Nusrat, Bondoc, Tiffany, Buckley, Trudy-Ann, Flores, Pamela Ruth, Kurt, Kardelen, Loganathan, Sangeetha, Mali, Tarandeep, Thompson, Laurie, Batten, Jennifer, Chan, Jennifer, Clark, John, Craig, Amy, De Castris-Garcia, Kim, Dharman, Sharon, Kelleher, Sarah, Nasser, Salimah, Pabon, Tammara, Rhodes, Michelle, Salsa, Rafael, Skelding, Julie, Stern, Daniel, Stewart, Kerry, Tavares, Erika Sendra, Weir, Shannon, Cho, Maria Zaccaria, Janus, Magdalena, Duku, Eric, Reid-Westoby, Caroline, Raso, Patricia, Offord, Amanda, Abraham, Emy, Ali, Sara, Anderson, Kelly, Arbess, Gordon, Baker, Jillian, Barozzino, Tony, Bergeron, Sylvie, Bloch, Gary, Bonifacio, Joey, Bowry, Ashna, Calpin, Caroline, Campbell, Douglas, Cheema, Sohail, Cheng, Elaine, Chisamore, Brian, Constantin, Evelyn, Danayan, Karoon, Das, Paul, De Guerra, Viveka, Derocher, Mary Beth, Do, Anh, Doukas, Kathleen, Egger, Anne, Farber, Allison, Freedman, Amy, Freeman, Sloane, Gazeley, Sharon, Grewal, Karen, Guiang, Charlie, Ha, Dan, Handford, Curtis, Hanson, Laura, Harrington, Leah, Jacobson, Sheila, Jagiello, Lukasz, Jansz, Gwen

Get full text

Preliminary Results of a Phase I Study of Nivolumab (BMS-936558) in Patients with Relapsed or Refractory Lymphoid Malignancies by Lesokhin, Alexander M., Ansell, Stephen M., Armand, Philippe, Scott, Emma C., Halwani, Ahmad, Gutierrez, Martin, Millenson, Michael M., Cohen, Adam D., Schuster, Stephen J., Lebovic, Daniel, Dhodapkar, Madhav V., Avigan, David, Chapuy, Bjoern, Ligon, Azra H., Rodig, Scott J., Cattry, Deepika, Zhu, Lili, Grosso, Joseph F., Kim, Su Young, Shipp, Margaret A., Borrello, Ivan, Timmerman, John

Get full text

Phase 1 Study Of The Novel Pan-Pim Kinase Inhibitor LGH447 In Patients With Relapsed/ Refractory Multiple Myeloma by Raab, Marc S, Ocio, Enrique M., Thomas, Sheeba K., Günther, Andreas, Lebovic, Daniel, Kumar, Shaji K, Jakubowiak, Andrzej J., Song, Dongweon, Xiang, Fang, Hynds, David, Vanasse, K. Gary, Goh, Yeow Tee

Get full text

Superior overall survival of patients with myeloma achieving very good partial response or better to initial treatment with bortezomib, pegylated liposomal doxorubicin, and dexamet... by Dytfeld, Dominik, Griffith, Kent A., Friedman, Judah, Lebovic, Daniel, Harvey, Colleen, Kaminski, Mark S., Jakubowiak, Andrzej J.

Get full text

Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131 I-tositumomab by Elstrom, Rebecca L., Ruan, Jia, Christos, Paul J., Martin, Peter, Lebovic, Daniel, Osborne, Joseph, Goldsmith, Stanley, Greenberg, June, Furman, Richard R., Avram, Anca, Putman, Ryan, Chapman, Erica, Mazumdar, Madhu, Griffith, Kent, Coleman, Morton, Leonard, John P., Kaminski, Mark S.

Get full text

Phase 1 Study of Radiosensitization Using Bortezomib in Patients with Relapsed Non-Hodgkin's Lymphoma Receiving Radioimmunotherapy by Elstrom, Rebecca L., Leonard, John P., Christos, Paul, Martin, Peter, Lebovic, Daniel, Osborne, Joseph, Goldsmith, Stanley J., Greenberg, June, Furman, Richard R., Ruan, Jia, Putman, Ryan, Chapman, Erica, Mazumdar, Madhu, Griffith, Kent A., Coleman, Morton, Kaminski, Mark S.

Get full text

Predictors Of Treatment Outcome With The Combination Of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) In Newly Diagnosed Multiple Myeloma (NDMM) by Jasielec, Jagoda, Dytfeld, Dominik, Griffith, Kent A., McDonnell, Kathryn, Lebovic, Daniel, Kandarpa, Malathi, Vesole, David H., Jagannath, Sundar, Mietzel, Melissa A., Vij, Ravi, Faham, Malek, Lee, Liana, van Beers, Erik H., van Vliet, Martin H., Levy, Joan, Alonge, Mattina, Rosebeck, Shaun, Kaminski, Mark S., Jakubowiak, Andrzej J.

Get full text